Nitric oxide synergistically potentiates interleukin-1β-induced increase of cyclooxygenase-2 mRNA levels, resulting in the facilitation of substance P release from primary afferent neurons: involvement of cGMP-independent mechanisms
- 31 October 2002
- journal article
- Published by Elsevier in Neuropharmacology
- Vol. 43 (5) , 868-876
- https://doi.org/10.1016/s0028-3908(02)00143-0
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- Regulation of Interleukin-8 Expression by Nitric Oxide in Human Pancreatic AdenocarcinomaJournal of Interferon & Cytokine Research, 2001
- Interleukin‐1β Induces Substance P Release from Primary Afferent Neurons Through the Cyclooxygenase‐2 SystemJournal of Neurochemistry, 1999
- Activation of Nuclear Factor κB by Nitric Oxide in Rat Striatal NeuronesJournal of Neurochemistry, 1999
- Regulation of the inducible cyclo‐oxygenase pathway in human cultured airway epithelial (A549) cells by nitric oxideBritish Journal of Pharmacology, 1997
- 5‐Hydroxytryptamine‐Facilitated Release of Substance P from Rat Spinal Cord Slices Is Mediated by Nitric Oxide and Cyclic GMPJournal of Neurochemistry, 1997
- Nitric oxide amplifies interleukin 1-induced cyclooxygenase-2 expression in rat mesangial cells.Journal of Clinical Investigation, 1996
- Function and Activation of NF-kappaB in the Immune SystemAnnual Review of Immunology, 1994
- Nitric oxide evokes pain in humans on intracutaneous injectionNeuroscience Letters, 1994
- Nitric oxide synthase‐like immunoreactivity in lumbar dorsal root ganglia and spinal cord of rat and monkey and effect of peripheral axotomyJournal of Comparative Neurology, 1993
- Nitric oxide, a novel neuronal messengerNeuron, 1992